Main field of activity
Transgene is part of European network about multiphysiological system:
Organoids, spheroids, organ-on-a-chip & bioprinted tissues;
Cancer & infectious disease;
Drug discovery, clinical drug efficacy, medical treatments, physiological responses, toxicity, drug safety, toxicology testing & personalized medecine.
Transgene is a French biotechnology focused on designing and developing targeted immunotherapies for the treatment of cancer and infectious diseases. Transgene develop promising drug candidates based on engineered viruses. Transgene carries on two major programs: technological program Invir.IO™ and personalized vaccine program myvac™. Invir.IO™ is dedicated to the design of the next generation of oncolytic viruses and myvac™ is an individualized MVA-based immunotherapy platform designed to integrate neoantigens. The company is based in Strasbourg and Lyon.
Google Maps est désactivé.
Boulevard Gonthier d’Andernach